As recently as mid-March 2022, Nike (NKE) shares were reasonably valued. Therefore, I acquired 100 additional shares at ~$123/share on March 11. Following this purchase, however, NKE's share price has run-up. I am now of the opinion Nike is slightly overvalued. I last reviewed NKE in this July 13 2021 post at which time I [...]
In my FFJ Portfolio – February 2022 Report, I list the companies in which I acquired additional shares in February. This monthly update was delayed until mid-March because I was away on a ski trip. Therefore, I also listed purchases made in the first half of March while on vacation. In this post, I explain [...]
This is my FFJ Portfolio - February 2022 Report. Previous monthly reports are accessible in the Archives and the month-end portfolio holdings are accessible here. On February 27th, I departed for a ski trip to various resorts in British Columbia. I did not return home until March 14th thus the reason for the delay in [...]
In my February 24, 2022 Ecolab - An Overvalued Dividend Aristocrat post at Dividend Power, I share why I am not adding to my Ecolab (ECL) position. ECL delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, optimize water and energy use, and improve operational efficiencies [...]
On February 16, 2022, Copart (CPRT) released Q2 and YTD2022 results. WOW! Copart continues to impress! In my January 8, 2022 post, I disclose a new CPRT position in an account for a young investor I am helping create a portfolio to achieve financial freedom. I also indicate my intent to establish a CPRT position [...]
3M (MMM) appeals to many investors because 64 consecutive years of dividend increases qualify it to be a Dividend King. This Dividend King is a train wreck, however, so this designation is no reason to invest in the company. Investing based on dividend yield and consecutive years of dividend increases is a fundamentally flawed method [...]
I initiated a Moody's Corporation (MCO) position in October 2018 at ~$142 and disclosed this purchase here. These shares were transferred between investment accounts for tax planning purposes in mid-March 2021 at ~$290. This transfer triggered a capital gain and a new adjusted cost base. Most recently, I analyzed MCO in this October 30, 2021 [...]
In my UPS is Unattractively Valued guest post published on February 10, 2022 at Dividend Power, I share my thoughts on why investors might want to wait for UPS's valuation to retrace to a more reasonable level. On February 1, 2022, UPS announced record results, strong FY2022 guidance, and a ~49% increase in the [...]
Intact Financial (IFC), Canada's largest provider of property and casualty (P&C) insurance with an estimated market share of 21%, has generated a 14% CAGR total shareholder return between 2010 - 2020. Intact Financial continues to impress having posted strong Q4 and FY2021 financial results. NOTE: All dollar values expressed in this post are Canadian currency. [...]
CME Group (CME) is a high-quality company. The challenge an investor currently faces by investing in this high-quality company is that will be difficult to generate attractive long-term total investment returns because the valuation is unreasonable. I recommend you invest in CME Group when its valuation improves. Immediately following my August 5, 2018 post, I [...]